The significance of dyserythropoiesis
Central diabetes insipidus revealing neuromeningeal localization of chronic myelomonocytic leukaemia
When should FDG-PET be used in the modern management of lymphoma?
Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking
The mechanisms of action of plasma exchange
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia
Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15
Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?
CXCR4 blockade and Sphingosine-1-phosphate activation facilitate engraftment of haematopoietic stem and progenitor cells in a non-myeloablative transplant model
Subcutaneous protein C concentrate in the management of severe protein C deficiency – experience from 12 centres
Single whole-leg compression ultrasound for exclusion of deep vein thrombosis in symptomatic ambulatory patients: a prospective observational cohort study
Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major
Blood oxidative stress markers and Plasmodium falciparum malaria in non-immune African children
Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions
Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma
A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia
Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia
No evidence for routine cerebrospinal fluid cytology in detecting asymptomatic central nervous system relapse in children with acute lymphoblastic leukaemia: 20 years’ experience of a UK primary treatment centre
8th Bari International Conference (BIC), 3–5 October 2014, in Bari, Italy